ConductScience.org, home

Trial · NCT04287985

Results by group199

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Number of Participants With Adverse Events Graded by SeverityVIS649 2 mg/kgTEAE with a maximum severity of mild19Participants
Number of Participants With Adverse Events Graded by SeverityVIS649 4 mg/kgTEAE with a maximum severity of mild22Participants
Number of Participants With Adverse Events Graded by SeverityVIS649 8 mg/kgTEAE with a maximum severity of mild22Participants
Number of Participants With Adverse Events Graded by SeverityPlaceboTEAE with a maximum severity of mild23Participants
Number of Participants With Adverse Events Graded by SeverityVIS649 2 mg/kgTEAE with a maximum severity of moderate7Participants
Number of Participants With Adverse Events Graded by SeverityVIS649 4 mg/kgTEAE with a maximum severity of moderate9Participants
Number of Participants With Adverse Events Graded by SeverityVIS649 8 mg/kgTEAE with a maximum severity of moderate8Participants
Number of Participants With Adverse Events Graded by SeverityPlaceboTEAE with a maximum severity of moderate3Participants
Number of Participants With Adverse Events Graded by SeverityVIS649 2 mg/kgTEAE with a maximum severity of severe2Participants
Number of Participants With Adverse Events Graded by SeverityVIS649 4 mg/kgTEAE with a maximum severity of severe2Participants
Number of Participants With Adverse Events Graded by SeverityVIS649 8 mg/kgTEAE with a maximum severity of severe1Participants
Number of Participants With Adverse Events Graded by SeverityPlaceboTEAE with a maximum severity of severe1Participants
Number of Participants With Adverse Events Graded by SeverityVIS649 2 mg/kgTEAE related to trial drug7Participants
Number of Participants With Adverse Events Graded by SeverityVIS649 4 mg/kgTEAE related to trial drug7Participants
Number of Participants With Adverse Events Graded by SeverityVIS649 8 mg/kgTEAE related to trial drug4Participants
Number of Participants With Adverse Events Graded by SeverityPlaceboTEAE related to trial drug5Participants
Number of Participants With Adverse Events Graded by SeverityVIS649 2 mg/kgTEAE related to trial drug with a maximum severity of Mild7Participants
Number of Participants With Adverse Events Graded by SeverityVIS649 4 mg/kgTEAE related to trial drug with a maximum severity of Mild7Participants
Number of Participants With Adverse Events Graded by SeverityVIS649 8 mg/kgTEAE related to trial drug with a maximum severity of Mild3Participants
Number of Participants With Adverse Events Graded by SeverityPlaceboTEAE related to trial drug with a maximum severity of Mild5Participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04287985/results